Variant report
Variant | nsv582723 |
---|---|
Chromosome Location | chr2:115536791-115541516 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145317451 | chr2:115538639-115538640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528189924 | chr2:115538670-115538671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147446619 | chr2:115538733-115538734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs117374499 | chr2:115538767-115538768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551159397 | chr2:115538768-115538769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565496216 | chr2:115538773-115538774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571352041 | chr2:115538790-115538791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs185809314 | chr2:115538825-115538826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531159626 | chr2:115538897-115538898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs139255295 | chr2:115538939-115538940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12613758 | chr2:115538962-115538963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs567686215 | chr2:115538982-115538983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190238503 | chr2:115538993-115538994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs556494975 | chr2:115538994-115538995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs141886021 | chr2:115539018-115539019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs369156675 | chr2:115539025-115539026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs180917002 | chr2:115539054-115539055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570259116 | chr2:115539055-115539056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs17043547 | chr2:115539056-115539057 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs568002139 | chr2:115539074-115539075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12611551 | chr2:115539077-115539078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs572671507 | chr2:115539082-115539083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs184884703 | chr2:115539090-115539091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs150000797 | chr2:115539140-115539141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574437858 | chr2:115539180-115539181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs543071946 | chr2:115539195-115539196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563248226 | chr2:115539221-115539222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532282106 | chr2:115539260-115539261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545682483 | chr2:115539299-115539300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112430544 | chr2:115539320-115539321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs145239541 | chr2:115539358-115539359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190132485 | chr2:115539433-115539434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs148751657 | chr2:115539452-115539453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs79640941 | chr2:115539463-115539464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570025552 | chr2:115539491-115539492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10167728 | chr2:115539506-115539507 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs181322352 | chr2:115539600-115539601 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566307738 | chr2:115539634-115539635 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs319845 | chr2:115539685-115539686 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs115624879 | chr2:115539714-115539715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186331713 | chr2:115539715-115539716 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191991536 | chr2:115539730-115539731 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs537107198 | chr2:115539750-115539751 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556722528 | chr2:115539761-115539762 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs319846 | chr2:115539766-115539767 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs142402777 | chr2:115539776-115539777 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559238701 | chr2:115539816-115539817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs570658521 | chr2:115539902-115539903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572773333 | chr2:115539905-115539906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs3036347 | chr2:115539906-115539907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroticism | 17667963 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:115538600-115539000 | Enhancers | Brain Anterior Caudate | brain |
2 | chr2:115538600-115539000 | Enhancers | Brain Cingulate Gyrus | brain |
3 | chr2:115538600-115539400 | Enhancers | Brain Inferior Temporal Lobe | brain |
4 | chr2:115538800-115539800 | Enhancers | Brain Substantia Nigra | brain |
5 | chr2:115539000-115539600 | Enhancers | Brain Hippocampus Middle | brain |
6 | chr2:115539000-115539800 | Enhancers | Brain Angular Gyrus | brain |
7 | chr2:115539600-115539800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr2:115539600-115541400 | Weak transcription | Brain Hippocampus Middle | brain |
9 | chr2:115539800-115545000 | Weak transcription | Brain Substantia Nigra | brain |
10 | chr2:115539800-115547000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr2:115541200-115541600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr2:115541200-115541600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr2:115541200-115541800 | Enhancers | Pancreas | Pancrea |
14 | chr2:115541400-115541600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr2:115541400-115542000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr2:115541400-115542000 | Enhancers | Brain Hippocampus Middle | brain |